Aktie A2QPMX MORINGA ACQUISITION CORP
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Moringa Acquisition Corp

Aktien

A2QPMX

KYG6S23K1085

MACA

Markt geschlossen - Nasdaq
Andere Börsenplätze
 22:30:00 10.05.2024 		% 5 Tage % 1. Jan.
11,14 USD -0,18 % Intraday Chart für Moringa Acquisition Corp -0,18 % +2,67 %
01.04. Moringa Acquisition Corp meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr CI
2023 Moringa Acquisition Corp meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 30. September 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Moringa Acquisition Corp Reports Earnings Results for the Full Year Ended December 31, 2023
Silexion, a Clinical-Stage, Oncology-Focused Biotechnology Company, to Become Publicly Traded Via Business Combination with Moringa Acquisition Corp
Silexion Ltd. entered into a business combination agreement to acquire Moringa Acquisition Corp for $68.9 million.
Moringa Acquisition Corp Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Moringa Acquisition Corp announced that it has received $0.154506 million in funding
MORINGA ACQUISITION CORP ANNOUNCES CONTRIBUTION TO TRUST ACCOUNT IN CONNECTION WITH PROPOSED EXTENSION
Moringa Acquisition Corp Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Holisto LTD cancelled the acquisition of Moringa Acquisition Corp from Moringa Sponsor, LP and others.
MORINGA ACQUISITION CORP : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)
Moringa Acquisition Corp Reports Earnings Results for the First Quarter Ended March 31, 2023
MORINGA ACQUISITION CORP Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)
Moringa Acquisition Corp Reports Earnings Results for the Full Year Ended December 31, 2022
Moringa Acquisition Corp Auditor Raises 'Going Concern' Doubt
MORINGA ACQUISITION CORP : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)
MORINGA ACQUISITION CORP : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)
Moringa Acquisition Corp announced that it has received $0.48 million in funding
MORINGA ACQUISITION CORP : Other Events, Financial Statements and Exhibits (form 8-K)
MORINGA ACQUISITION CORP : Other Events, Financial Statements and Exhibits (form 8-K)
MORINGA ACQUISITION CORP : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)
MORINGA ACQUISITION CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2QPMX Aktie
  4. Nachrichten Moringa Acquisition Corp
  5. Andere Sprachen